Alfuzosin D7 Hydrochloride
| Product Name | Alfuzosin D7 Hydrochloride |
|---|---|
| Alternate Names | Alfuzosin Stable Isotopes, Stable Isotopes of Alfuzosin |
| CAT No. | CS-O-02907 |
| CAS No. | 1276197-14-8 |
| Category | Stable Isotopes |
| Stock | Enquire |
| Mol. Wt. | Not Available |
| Mol. For. | Not Available |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Alfuzosin |
| Smileys | NC1=NC(N(C)CCCNC(C2([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])O2)=O)=NC3=C1C=C(OC)C(OC)=C3.Cl |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Alfuzosin D7 Hydrochloride is a deuterium-labeled version of Alfuzosin Hydrochloride, a medication used in the treatment of benign prostatic hyperplasia (BPH). It is a selective alpha-1 adrenergic receptor antagonist that works by relaxing the muscles in the prostate and bladder neck, which helps to improve urine flow and reduce symptoms such as difficulty urinating, frequent urination, and nocturia.
The chemical formula of Alfuzosin D7 Hydrochloride is C19H27D7ClN4O4S, and it has a molecular weight of 454.05 g/mol. It is a white to off-white powder that is soluble in water and has a pKa of 8.8.
Alfuzosin D7 Hydrochloride is typically administered orally in the form of a tablet, and the recommended dose is usually 10 mg once daily after a meal. The medication is metabolized in the liver by the cytochrome P450 enzyme system, primarily by CYP3A4, and is excreted in the urine and feces.
Like other alpha-1 adrenergic receptor antagonists, Alfuzosin D7 Hydrochloride may cause side effects such as dizziness, headache, fatigue, and gastrointestinal disturbances. Patients with liver or kidney impairment, hypotension, or a history of QT prolongation should use caution when taking this medication. It should also be avoided in patients taking certain medications, such as ketoconazole, itraconazole, or ritonavir, that can increase the concentration of Alfuzosin D7 Hydrochloride in the body.
Get an Instant Quote
Related Compounds
Alfuzosin 13CD3 | Alfuzosin hydrochloride D3 | N2-Methyl Alfuzosin-d7 Hydrochloride | Alfuzosin hydrochloride D6 | Alfuzosin D7 |